Health care stocks were flat to lower premarket Thursday as the Health Care Select Sector SPDR Fund (XLV) was down 0.4% and the iShares Biotechnology ETF (IBB) was recently inactive.
BrightSpring Health Services (BTSG) shares advanced by 5% after the company reported higher Q4 adjusted earnings and revenue. The company also raised its 2025 revenue outlook.
Aquestive Therapeutics (AQST) shares were down nearly 7% after the company reported a wider Q4 net loss as revenue fell during the period.
QIAGEN (QGEN) shares were up nearly 2% after the company said the US Food and Drug Administration has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, marking the company's second FDA clearance of a QIAstat-Dx panel in 2025.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。